HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xueyan He Selected Research

Proteins (Proteins, Gene)

3/2024Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1.
1/2022LINC00922 promotes deterioration of gastric cancer.
1/2021Knockdown of Oligosaccharyltransferase Subunit Ribophorin 1 Induces Endoplasmic-Reticulum-Stress-Dependent Cell Apoptosis in Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xueyan He Research Topics

Disease

14Breast Neoplasms (Breast Cancer)
04/2024 - 01/2018
13Neoplasms (Cancer)
04/2024 - 11/2017
4Triple Negative Breast Neoplasms
01/2024 - 01/2018
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2023
1Fibrosis (Cirrhosis)
01/2022
1Bronchiolitis Obliterans
01/2022
1Lung Injury
01/2022
1Tics (Tic)
12/2021
1Carcinogenesis
12/2021
1Neoplasm Metastasis (Metastasis)
01/2018
1Stomach Neoplasms (Stomach Cancer)
11/2017
1Lymphatic Metastasis
11/2017

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2021
3Aldehyde DehydrogenaseIBA
12/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2017
2Interleukin-1 Type II ReceptorsIBA
04/2024 - 01/2020
2taxaneIBA
03/2024 - 01/2018
2LigandsIBA
01/2023 - 01/2018
2ChemokinesIBA
01/2023 - 01/2018
2Docetaxel (Taxotere)FDA Link
01/2023 - 01/2022
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2024
1S 27IBA
01/2024
1Lovastatin (Mevacor)FDA LinkGeneric
01/2024
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2023
1SincalideFDA Link
12/2023
1MethyltransferasesIBA
12/2023
1SB 225002IBA
01/2023
1Chemokine ReceptorsIBA
01/2023
1PlatinumIBA
01/2022
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2022
1TitaniumIBA
01/2022
1IronIBA
01/2022
1Particulate MatterIBA
01/2022
1ferric ferrocyanide (Prussian blue)FDA Link
01/2022
1EnzymesIBA
12/2021
1Disulfiram (Antabuse)FDA Link
12/2021
1GemcitabineFDA Link
12/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2021
1Uncoupling Protein 1IBA
01/2021
1dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA
01/2021
1ribophorinIBA
01/2021
1Pemetrexed (MTA)FDA Link
01/2020
1Protein Kinase CIBA
01/2020
1NucleoproteinsIBA
01/2020
1Notch4 ReceptorIBA
01/2020
1moesinIBA
01/2020
1glycylpeptide N-tetradecanoyltransferaseIBA
11/2018
1Protein Kinases (Protein Kinase)IBA
01/2018
1tocilizumab (atlizumab)FDA Link
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
13- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA
01/2018
1Annexin A3IBA
01/2018
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1NF-kappa B (NF-kB)IBA
01/2018
1p38 Mitogen-Activated Protein KinasesIBA
01/2018
12,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA
01/2018
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
11/2017

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2020 - 01/2018
2Therapeutics
03/2024 - 01/2020
1Neoadjuvant Therapy
03/2024
1Synchrotrons
01/2022